Ascension Medical Group Southeast Wisconsin - Mayfair Road — Wauwatosa, Wisconsin

Ascension Medical Group Southeast Wisconsin - Mayfair Road is a clinical research site located in Wauwatosa, Wisconsin, United States 53226.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Ascension Medical Group Southeast Wisconsin - Mayfair Road has participated in 54 clinical trials with 51 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ascension Medical Group Southeast Wisconsin - Mayfair Road?

Ascension Medical Group Southeast Wisconsin - Mayfair Road has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ascension Medical Group Southeast Wisconsin - Mayfair Road conducted?

Ascension Medical Group Southeast Wisconsin - Mayfair Road has 54 clinical trials on record, with 51 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7.

Is Ascension Medical Group Southeast Wisconsin - Mayfair Road accredited by Crixeo Health?

Ascension Medical Group Southeast Wisconsin - Mayfair Road has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ascension Medical Group Southeast Wisconsin - Mayfair Road?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.